Omnifit Threaded Acetabular Component
510(k) K861723
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK861723 | Date9 Jun 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- (Modified) Omnifit Threaded Acetabular Component
- 510(k) Number
- FDA Product Code
- KWA
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3330
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Omnifit Threaded Acetabular Component is a semi-constrained, uncemented metal acetabular prosthesis for the hip. Designed to replace the damaged or diseased acetabulum, it provides a stable bearing surface for the femoral component in total hip arthroplasty, ensuring proper articulation and load distribution within the hip joint.
This device is intended for surgical use in orthopedic procedures and is supplied as a reusable medical implant. It is classified as a Class III device under FDA regulations, with a 510(k) clearance under the Traditional pathway. The component is threaded for secure fixation to the pelvic bone and is available in multiple sizes to accommodate varying anatomical requirements. Sterility and handling instructions are specified by the manufacturer for preoperative preparation.
Other devices from Osteonics Corp.
Questions
AI-generated answers, 18 Sep 2026
What types of hip procedures is the Omnifit Threaded Acetabular Component designed for, and why is it considered semi-constrained?
The Omnifit Threaded Acetabular Component is designed for total hip arthroplasty procedures where the damaged or diseased acetabulum needs replacement. It is classified as semi-constrained because its design allows for some degree of movement between the acetabular component and the femoral head, while still providing stability to the hip joint. This balance helps ensure proper articulation and load distribution, reducing the risk of dislocation compared to unconstrained designs.
Is the Omnifit Threaded Acetabular Component reusable or single-use, and how does this affect its clinical use?
The Omnifit Threaded Acetabular Component is explicitly described as a reusable medical implant, meaning it is intended for multiple surgical uses after proper cleaning, sterilization, and handling as directed by the manufacturer. This makes it cost-effective for repeated procedures but requires strict adherence to sterilization protocols to ensure patient safety and device integrity between uses.
What size options are available for the Omnifit Threaded Acetabular Component, and how does this accommodate different patients?
The Omnifit Threaded Acetabular Component comes in multiple sizes to match varying anatomical requirements of patients. The exact range of sizes isn’t specified here, but the availability of diverse options ensures compatibility with different pelvic morphologies, improving fixation stability and reducing the need for custom modifications during surgery.
How is the Omnifit Threaded Acetabular Component fixed to the pelvis, and what advantages does this threaded design offer?
The Omnifit Threaded Acetabular Component features a threaded design that allows it to be securely screwed into the pelvic bone, providing primary fixation. This threaded mechanism enhances stability by engaging the bone threads, reducing the risk of loosening over time—a common issue with unthreaded acetabular components. The secure fixation also supports early weight-bearing post-surgery.
What regulatory pathway was used for FDA clearance of this device, and what does that mean for its clinical use?
The Omnifit Threaded Acetabular Component received FDA clearance through the 510(k) Traditional pathway, with a determination of substantial equivalence to a predicate device. This means the FDA reviewed it against an existing, legally marketed device and found it to have the same intended use and technological characteristics. Clinically, this clearance indicates the device meets FDA standards for safety and effectiveness, but surgeons should still follow manufacturer guidelines for proper use.